ACI Files Comments with the FTC Regarding PBM Business Practices and their Impact on Drug Prices

The Federal Trade Commission is currently collecting public comments on the “Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers.” Today ACI filed its comments with the FTC. The comments are available here.

Pociask’s Op-ed In THE HILL’s Congressional Blog

The Solution Can Sometimes Be Worse than the Problem (Published in THE HILL’s Congressional Blog on January 6, 2012 as “FTC should block proposed Express Scripts-Medco merger”  The perfect example of the law of unintended consequences can be found in the 7 million acres from Texas to Washington DC that is covered by Kudzu vines.  […]